Collaborating university: Università della Svizzera italiana
The first edition of the Certificate of Advanced Studies in Gastrointestinal cancer will begin in June 2022 and is the first competence programme to focus on the improvement of both the clinical and scientific capability of oncologists, ensuring better-quality management of patients with gastrointestinal cancers.
This programme, which is offered on a part-time basis over 15 months, is divided into a seminar module (three seminars) and six online modules.
Upon successful completion of the programme and after passing the final exam, participants will obtain an academic certificate issued by the European School of Oncology and the Università della Svizzera italiana assigning 14 European Credit Transfer and Accumulation System Points (ECTS) and equalling a work load of 381 didactic hours and a diploma supplement issued by the Università della Svizzera italiana.
For further information please contact email@example.com
Admission to the Certificate of Advanced Studies in Gastrointestinal cancer programme will be by competitive application only and the selection will be based on the eligibility criteria and on the selection procedure.
Applications will be considered if received completed with all required documents and within the deadline. Attendance is limited to 25 participants.
Decisions on admissions are made by the appointed Programme Chair.
To obtain the Certificate of Advanced Studies in Gastrointestinal cancer, it will be compulsory that participants will attend all seminars and modules according to the provided timeline.
The organisers bear no responsibility for untoward events in relation to the participation in the seminars. Participants are advised to take out their own personal and travel insurance coverage.
The CAS-GI program is designed for medical doctors (medical oncology, radiation oncology, radiology, nuclear medicine or pathology), but it is equally accessible to graduates in natural sciences, who are engaged in the field of oncology, especially in the field of gastrointestinal cancer.
Click here to download the Regulations document.
Applications for the 2022/2023 cohort are no longer being accepted.
The tuition fee is EUR 5,400. A discounted fee of EUR 3,000 is implemented and made available to participants from low, lower middle and upper middle-income economies as defined by The World Bank for the year 2022.
The tuition fee includes:
Cancellation should be submitted in writing and refund of the first deposit payment will be processed when cancellation is notified by 30 October 2022.
The College of the European School of Oncology (ESCO) will offer one full tuition scholarship to a fellow or graduate enrolled in ESCO for the year 2022. You may request to be considered for this scholarship on Part II of the application template. ESCO enrolment/renewal must be carried out before the application deadline in order to be consider for this benefit.
Overall Scientific Director
Conceptual Development and Organisation